TP53 and non-small cell lung carcinoma: Ji et al. identified p53-induced protein with a death domain (PIDD) as a KEAP1-interacting partner, which promotes NRF2 stabilization and increases chemoresistance in H1299 NSCLC cells both in vitro and in vivo [169].